{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:43:28Z","timestamp":1788194608773,"version":"build-2803163510"},"reference-count":16,"publisher":"Japan Atherosclerosis Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.5551\/jat.50435","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T22:05:36Z","timestamp":1569362736000},"page":"485-488","source":"Crossref","is-referenced-by-count":21,"title":["Statin Intolerance\u2014An Asian Perspective"],"prefix":"10.5551","volume":"27","author":[{"given":"Brian","family":"Tomlinson","sequence":"first","affiliation":[{"name":"Research Center for Translational Medicine, Shanghai East Hospital Affiliated to Tongji University School of Medicine"},{"name":"Faculty of Medicine, Macau University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Chan","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Min","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Shanghai East Hospital, Tongji University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Alonso R, Cuevas A, and Cafferata A. Diagnosis and Management of Statin Intolerance. J Atheroscler Thromb, 2019; 26: 207-215","DOI":"10.5551\/jat.RV17030"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Stroes ES, Thompson PD, Corsini A, et al. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. European Heart Journal, 2015; 36: 1012-1022","DOI":"10.1093\/eurheartj\/ehv043"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Mancini GB, Tashakkor AY, Baker S, et al. Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update. Can J Cardiol, 2013; 29: 1553-1568","DOI":"10.1016\/j.cjca.2013.09.023"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Newman CB, Preiss D, Tobert JA, et al. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol, 2019; 39: e38-e81","DOI":"10.1161\/ATV.0000000000000081"},{"key":"5","unstructured":"5) Chien SC, Chen PS, Huang YH, et al. 2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance. J Formos Med Assoc, 2018;"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Naito R, Miyauchi K, and Daida H. Racial Differences in the Cholesterol-Lowering Effect of Statin. J Atheroscler Thromb, 2017; 24: 19-25","DOI":"10.5551\/jat.RV16004"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Tomlinson B, Chan P, and Liu ZM. Statin Responses in Chinese Patients. J Atheroscler Thromb, 2018; 25: 199-202","DOI":"10.5551\/jat.40204"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Nagar SP, Rane PP, Fox KM, et al. Treatment Patterns, Statin Intolerance, and Subsequent Cardiovascular Events Among Japanese Patients With High Cardiovascular Risk Initiating Statin Therapy. Circ J, 2018; 82: 1008-1016","DOI":"10.1253\/circj.CJ-17-0811"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Chan JCM, Ng MH, Wong RSM, et al. A case of simvastatin-induced myopathy with SLCO1B1 genetic predisposition and co-ingestion of linagliptin and Stevia rebaudiana. J Clin Pharm Ther, 2019;","DOI":"10.1111\/jcpt.12805"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Cheung TF, Cheuk KY, Yu FW, et al. Prevalence of vitamin D insufficiency among adolescents and its correlation with bone parameters using high-resolution peripheral quantitative computed tomography. Osteoporos Int, 2016; 27: 2477-2488","DOI":"10.1007\/s00198-016-3552-4"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Chen CH, Liu LK, Chen MJ, et al. Associations between vitamin D deficiency, musculoskeletal health, and cardiometabolic risk among community-living people in Taiwan: Age and sex-specific relationship. Medicine (Baltimore), 2018; 97: e13886","DOI":"10.1097\/MD.0000000000013886"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13) Sullivan D, Olsson AG, Scott R, et al. Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial. JAMA, 2012; 308: 2497-2506","DOI":"10.1001\/jama.2012.25790"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14) Stroes E, Colquhoun D, Sullivan D, et al. Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebocontrolled phase 3 clinical trial of evolocumab. J Am Coll Cardiol, 2014; 63: 2541-2548","DOI":"10.1016\/j.jacc.2014.03.019"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15) Nissen SE, Stroes E, Dent-Acosta RE, et al. Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial. JAMA, 2016; 315: 1580-1590","DOI":"10.1001\/jama.2016.3608"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16) Moriarty PM, Thompson PD, Cannon CP, et al. Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial. J Clin Lipidol, 2015; 9: 758-769","DOI":"10.1016\/j.jacl.2015.08.006"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17) Laufs U, Banach M, Mancini GBJ, et al. Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance. J Am Heart Assoc, 2019; 8: e011662","DOI":"10.1161\/JAHA.118.011662"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/27\/5\/27_50435\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T07:03:29Z","timestamp":1588835009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/27\/5\/27_50435\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.50435","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}